Stephan Reynier
Oficial de Cumplimiento en CELLECTIS S.A. .
Fortuna: 51 656 $ al 31/05/2024
Perfil
Stephan Reynier currently works at Cellectis SA, as Chief Regulatory & Compliance Officer from 2011.
Mr. Reynier also formerly worked at Gilead Sciences, Inc., as Associate Medical Affairs Director-European Region from 2002 to 2006, Voisin Consulting, Inc., as Senior Director, Takara Bio Europe AB, as Head-Project Management & Regulatory Affairs, and Ectycell SASU, as Head-Programs from 2011 to 2014.
Mr. Reynier received his graduate degree from the University of Toronto.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CELLECTIS SA
0.03% | 14/02/2024 | 19 744 ( 0.03% ) | 51 656 $ | 31/05/2024 |
Cargos activos de Stephan Reynier
| Empresas | Cargo | Inicio |
|---|---|---|
| CELLECTIS S.A. | Oficial de Cumplimiento | 01/04/2011 |
Antiguos cargos conocidos de Stephan Reynier.
| Empresas | Cargo | Fin |
|---|---|---|
Ectycell SASU
 Ectycell SASU BiotechnologyHealth Technology Ectycell SASU produces and sales stem cells. It offers pluripotent stem cells that can be used to develop drugs and model diseases. The company was founded in September 2009 and is headquartered in Romainville, France. | Corporate Officer/Principal | 01/01/2014 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/06/2006 |
Voisin Consulting, Inc.
 Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Voisin Consulting, Inc. provides product development consulting services. It guides biotechnology, pharmaceutical and medical technology manufacturers throughout product development and commercialization. The company was founded by Emanuelle M. Viosin in 1997 and is headquartered in Cambridge, MA. | Director/Miembro de la Junta | - |
Takara Bio Europe AB
 Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Consejero General | - |
Formación de Stephan Reynier.
| University of Toronto | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| CELLECTIS S.A. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Ectycell SASU
Ectycell SASU BiotechnologyHealth Technology Ectycell SASU produces and sales stem cells. It offers pluripotent stem cells that can be used to develop drugs and model diseases. The company was founded in September 2009 and is headquartered in Romainville, France. | Health Technology |
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Commercial Services |
Voisin Consulting, Inc.
Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Voisin Consulting, Inc. provides product development consulting services. It guides biotechnology, pharmaceutical and medical technology manufacturers throughout product development and commercialization. The company was founded by Emanuelle M. Viosin in 1997 and is headquartered in Cambridge, MA. | Commercial Services |
- Bolsa de valores
- Insiders
- Stephan Reynier
